Compare Cytokinetics Inc (CYTK) vs Dollar Tree, Inc. (DLTR) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Cytokinetics Inc vs Dollar Tree, Inc. — how do they compare? Cytokinetics Inc trades at $76.67 (market cap $10.63B), while Dollar Tree, Inc. trades at $127.65 (market cap $24.61B). The key difference: Dollar Tree, Inc. is far larger — about 2.3× Cytokinetics Inc's market cap. Which is the better fit depends on your goals.
| CYTK | DLTR | |
|---|---|---|
Market Cap | $10.63B | $24.61B |
Sector | Technology | Health |
52-Week High | $87.26 | $141.21 |
52-Week Low | $34.31 | $85.04 |
Enterprise Value | $10.74B | $31.20B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Cytokinetics Inc
Cytokinetics is a biopharmaceutical company focused on muscle biology. It develops muscle activators and inhibitors as potential treatments for debilitating diseases where muscle performance is compromised or declining.
Read more on CYTK →About Dollar Tree, Inc.
Dollar Tree operates discount stores in the U.S. and Canada, including 8,647 shops under its namesake banner and 8,016 Family Dollar units (as of the end of fiscal 2021). The eponymous chain features branded and private-label goods, generally at a $1.25 price. Around 45% of Dollar Tree stores' fiscal 2021 sales came from consumables (including food, health and beauty, and household paper and cleaning products), nearly 50% from variety items (including toys and housewares), and just over 5% from seasonal goods. Family Dollar features branded and private-label goods at prices generally ranging from $1 to $10, with over 76% of fiscal 2021 sales from consumables, 9% from seasonal/electronic items (including prepaid phones and toys), 8% from home products, and 6% from apparel and accessories.
Read more on DLTR →
